U.S. Wealth WatcherCelebrating Political Fortunes
‹ Lobbying

Dynavax Technologies

CA · 4 filings, 2025

Lobbying spend · 2025
$500K
to shape legislation
About the organization

Valneva COVID-19 vaccine (VLA2001) is a COVID-19 vaccine developed by European specialty vaccine company Valneva SE in collaboration with the American biopharmaceutical company Dynavax Technologies. via Wikipedia ↗

1Lobbies on

No sectors mapped yet.

2Through these firms · 1

DYNAVAX TECHNOLOGIES CORP.